Point72 (DIFC)’s OnKure Therapeutics OKUR Stock Holding History

Point72 (DIFC)’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-502	Closed	-$7.58K	–	1914
2024 Q2	$7.58K	Buy	+502	New	+$8.51K	﹤0.01%	1334

Other funds holding OKUR

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 (DIFC)'s OKUR Position: Q3 2024 in Review

Point72 (DIFC) sold out of OnKure Therapeutics (OKUR) in Q3 2024, closing a stake of 502 shares — an estimated $7.58K sold.

Point72 (DIFC) first reported a position in OKUR in Q2 2024 and held it in 1 quarter. The position peaked at $7.58K in Q2 2024. 51 funds tracked by Wall St. Rank hold OKUR as of Q3 2024.

Point72 (DIFC) reported no remaining OnKure Therapeutics position as of Q3 2024 after selling out during the quarter.
Point72 (DIFC) sold 502 OnKure Therapeutics shares in Q3 2024, an estimated $7.58K.
Point72 (DIFC) first reported a position in OnKure Therapeutics in Q2 2024 and held it in 1 quarter.
Point72 (DIFC)'s OnKure Therapeutics position peaked at $7.58K in Q2 2024.
51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q3 2024.

Based on Point72 (DIFC)'s 13F filing for Q3 2024, filed 14 Nov 2024.